Table 2. Assessment of paracrine growth effects after cell therapy
|
|
CSC-treated rats |
Untreated rats |
Sham-operated rats |
|
Capillary length density, mm/mm3 |
3,312 ± 541 |
3,152 ± 489 |
3,450 ± 518 |
Capillary length density in the surviving myocardium. Data are mean ± SEM. n = 7 in each group.
|
|
CSC-treated rats |
Untreated rats |
Sham-operated rats |
|
Ki67POS myocytes (total), % |
0.59 ± 0.17 |
0.45 ± 0.13 |
0.32 ± 0.16 |
|
Ki67POS/EGFPNEG myocytes, % |
0.48 ± 0.18 |
0.45 ± 0.13 |
|
|
Ki67POS/EGFPPOS myocytes, % |
0.11 ± 0.04 |
|
|
Quantitative assessment of myocyte cell cycle status in the periinfarct area by Ki67 expression. Data are mean ± SEM. %, percent of all cardiac myocytes (both EGFPPOS and EGFPNEG). n = 8 in each group.